Organization · Venture Capital
Bio & Tech Smart Capital
Bio & Tech Smart Capital is a venture capital fund based in Santiago de Compostela, Galicia, Spain, specializing in early-stage investments in biotechnology and life sciences. The fund aims to support the development of the Galician life sciences sector by investing in startups and spin-offs from universities and innovation labs.
Overview
What Bio & Tech Smart Capital does
What Bio & Tech Smart Capital is
Bio & Tech Smart Capital is a venture capital fund based in Santiago de Compostela, Galicia, Spain, specializing in early-stage investments in biotechnology and life sciences. The fund aims to support the development of the Galician life sciences sector by investing in startups and spin-offs from universities and innovation labs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Bio & Tech Smart Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Bio & Tech Smart Capital as a funder
Investment thesis
Bio&Tech Smart Capital invests in transformative biotech and life sciences startups, focusing on projects that demonstrate social impact and profitability.
Focus narrative
The fund focuses on investing in digital technologies applied to life sciences, biotechnology, and medical diagnostics and devices. It seeks to support projects that align with its expertise and demonstrate potential for social impact and profitability, with a commitment to investing in 30-40 companies, particularly in Galicia.
Value beyond capital
Bio&Tech Smart Capital adds value to its portfolio companies by leveraging the team's extensive experience and networks to facilitate market access and scaling opportunities.
Terms and economics
- Typical check
- $200,000–$5,000,000
- Sweet spot
- $2,000,000
Focus and fit
- Stages
- Seed · Series A
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 2
Portfolio context
Notable portfolio companies include Oncostellae, a biopharmaceutical company focused on oncology and immunology drug discovery, and ADNTRO Genetics, which is developing a proprietary genetic test for personalized preventive medicine recommendations.
Common questions
What to know about Bio & Tech Smart Capital
Upseed classifies Bio & Tech Smart Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.